Similarly, Ulrichs et al documented the IFN-γ ELISpot response to ESAT-6 in 10 adult patients with pulmonary TB prior to and 60 days after starting anti-tuberculous treatment [29]. This evidence concerns the gene IFNG and pulmonary tuberculosis.